T3	Subject 34 99	patient with BCR-ABL (ela2) positive acute lymphoblastic leukemia
T5	Effect 114 134	tumor lysis syndrome
T6	Treatment 141 171	10-day treatment with imatinib
T8	Drug 163 171	imatinib
T9	Time_elapsed 141 147	10-day
T10	Treat-Disorder 47 99	BCR-ABL (ela2) positive acute lymphoblastic leukemia
T4	Adverse_event 104 113	developed
E1	Adverse_event:T4